Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile
Citations Over TimeTop 1% of 2002 papers
Abstract
A total of 271 patients were prospectively followed up to determine whether patients whose hospital stay is complicated by diarrhea due to Clostridium difficile experience differences in cost and length of stay and survival rates when compared with patients whose stay is not complicated by C. difficile-associated diarrhea. Forty patients (15%) developed nosocomial C. difficile-associated diarrhea. These patients incurred adjusted hospital costs of $3669--that is, 54% (95% confidence interval [CI], 17%-103%)--higher than patients whose course was not complicated by C. difficile-associated diarrhea. The extra length of stay attributable to C. difficile-associated diarrhea was 3.6 days (95% CI, 1.5-6.2). C. difficile-associated diarrhea was not associated with excess 3-month or 1-year mortality after adjustment for age, comorbidity, and disease severity. On the basis of the findings of this study, a conservative estimate of the cost of this disease in the United States exceeds $1.1 billion per year.
Related Papers
- → Comorbidity in head and neck cancer: A critical appraisal and recommendations for practice(2010)238 cited
- → Elderly patients with head and neck cancer: the influence of comorbidity on choice of therapy, complication rate, and survival(2005)66 cited
- → Health Care Resource Utilization And Costs Associated With HIV-Positive Patients With Comorbidity Versus HIV-Negative Patients With Comorbidity(2017)4 cited
- → Detection and characterization of Clostridium difficile infections tracking the trends of Clostridium difficile culture(2016)
- Influence of comorbidity on the choice of treatment and survival of elderly patients with advanced non-small cell lung cancer(2008)